Loading...

Major Indexes

Discounted Cash Flow (DCF) Analysis Unlevered


Ampio Pharmaceuticals Inc.

Ampio Pharmaceuticals Inc. (AMPE)

$0.5572
0.0016 (+0.29%)

Operating Data

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue 0.050.081.16--------
Revenue (%)
EBITDA -24.39-37.48-31.75--------
EBITDA (%)
EBIT -24.53-38.13-33.30--------
EBIT (%)
Depreciation 0.140.651.55--------
Depreciation (%)

Balance Sheet Data

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Total Cash 26.3150.3226.96--------
Total Cash (%)
Account Receivables -----------
Account Receivables (%)
Inventories -----------
Inventories (%)
Accounts Payable 1.903.302.88--------
Accounts Payable (%)
Capital Expenditure 1.648.670.24--------
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 0.5,572
Diluted Shares Outstanding 131.14
Cost of Debt
Tax Rate 0.00
After-tax Cost of Debt 0.05
Risk-Free Rate
Market Risk Premium
Cost of Equity 10.28
Total Debt 1.21
Total Equity 73.07
Total Capital 74.28
Debt Weighting 1.63
Equity Weighting 98.37
Wacc

Build Up Free Cash

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue 0.050.081.16--------
EBITDA -24.39-37.48-31.75--------
EBIT -24.53-38.13-33.30--------
Tax Rate 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIAT -24.53-38.13-33.30--------
Depreciation 0.140.651.55--------
Accounts Receivable -----------
Inventories -----------
Accounts Payable -1.40-0.42--------
Capital Expenditure --7.038.43--------
UFCF -24.39-43.10-23.74--------
WACC
PV UFCF ----
SUM PV UFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 10.19
Free cash flow (t + 1) -
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -
Equity Value -
Shares Outstanding 131.14
Equity Value Per Share -